# A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

> **NCT04400786** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 196 (estimated)

## Conditions studied

- Ankylosing Spondylitis
- Therapeutic Agent Toxicity

## Interventions

- **PROCEDURE:** intermittent treatment
- **PROCEDURE:** continuous treatment

## Key facts

- **NCT ID:** NCT04400786
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-07
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2020-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400786, "A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04400786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*